MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Nigral stimulation for the treatment of refractory gait disturbances in Parkinson’s disease

    M. Carmona-Abellán, D. Moreno, M. Alegre, J. Guridi, R. Luquin (Pamplona, Spain)

    Objective: Evaluate the effect of SNr stimulation on freezing of gait and analyse changes in local field potentials. We describe an early-onset Parkinson´s disease patient…
  • 2018 International Congress

    Dyskinesia-hyperpyrexia syndrome (DHS) after sudden interruption of deep brain stimulation and increase of oral dopaminergic therapy: A case report

    F. Dematteis, A. Cormio, C. Fronda, M. Lanotte, M. Zibetti, S. Amarù, L. Lopiano, M. Rizzone (Rivoli, Italy)

    Objective: To report the case of a PD patient treated with bilateral deep brain stimulation of subthalamic nucleus (STN-DBS) who developed DHS after the sudden…
  • 2018 International Congress

    An investigation of the potential neuroprotective role of curcumin in Parkinson’s disease patient-derived fibroblasts

    S. Abrahams, C. vander Merwe, A. Neethling, J. Carr, S. Bardien (Cape Town, South Africa)

    Objective: To investigate if the protective effects of curcumin previously observed in SH-SY5Y cells are also found in patient-derived fibroblasts from Parkinson’s disease patients. Background:…
  • 2018 International Congress

    Respiratory Complaints in Individuals with Spinocerebelar Ataxia Type 2

    N. Mello, H. Teive (Curitiba, Brazil)

    Objective: Verify the presence of respiratory complaints and dysfunction in individuals with spinocerebellar ataxia type 2 (SCA2).SCA2 is characterized by cerebellar ataxia, accompanied by dysarthria,…
  • 2018 International Congress

    Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial

    A. Benussi, V. Dell'Era, V. Cantoni, E. Bonetta, R. Grasso, R. Manenti, M. Cotelli, A. Padovani, B. Borroni (Brescia, Italy)

    Objective: The present study investigated whether a two-weeks' treatment with cerebellar anodal and spinal cathodal transcranial direct current stimulation (tDCS) could reduce symptoms in patients…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177

Most Viewed Abstracts

  • This Month
  • All Time
  • Dopaminergic imaging in patients with basal ganglia calcification presenting with parkinsonism
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley